Comparison of the effects of zoledronic acid versus denosumab on bone metabolism, inflammatory response, and immunoglobulins in breast cancer patients with bone metastases
In the treatment of BC with bone metastases, DEN demonstrated superior benefits for bone metabolism, while ZA showed better regulation of inflammatory response and immune function.
Authors
- Hailong Yang (ORCID: https://orcid.org/0000-0003-0223-0419)
- Zhi Wang (ORCID: https://orcid.org/0000-0002-5276-1413)
- Xian Zhang (ORCID: https://orcid.org/0000-0003-4079-9470)
- Jin-Feng Tong
Institutions
- Jiujiang First People's Hospital (CN)
Publication Details
- Journal
- Journal of Medical Biochemistry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5937/jomb0-56984
- Citations
- 1
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.05